A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine

Get answers to your Arrhythmia questions.
Dr. Shorofsky’s Bio | Q&A Archive
Preexcitation syndrome; WPW
Medication may be used to control or prevent rapid heart beating. These include adenosine, antiarrhythmics, and amiodarone.
If the heart rate does not return to normal with medication, doctors may use a type of therapy called electrical cardioversion (shock).
The current preferred therapy for Wolff-Parkinson-White syndrome is catheter ablation. This procedure involves inserting a tube (catheter) into an artery through a small cut near the groin up to the heart area. When the tip reaches the heart, the small area that is causing the fast heart rate is destroyed using a special type of energy called radiofrequency.
Open heart surgery may also provide a permanent cure for Wolff-Parkinson-White syndrome. However, surgery is usually done only if the patient must have surgery for other reasons.
Catheter ablation cures this disorder in most patients. The success rate for the procedure ranges between 85 - 95%. Success rate will vary depending on location of accessory pathway and number of accessory pathways.
The most severe form of a rapid heart beat is ventricular fibrillation. It may rapidly lead to shock, and requires emergency treatment (cardioversion).
Call your health care provider if symptoms of Wolff-Parkinson-White develop, or if you have this disorder and symptoms get worse or do not improve with treatment.
Olgin JE, Zipes DP. Specific arrhythmias: diagnosis and treatment. Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. St. Louis, Mo: WB Saunders; 2007:chap 35.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885